PT - JOURNAL ARTICLE AU - Gerges, Christian AU - Gerges, Mario AU - Lang, Marie AU - Mascherbauer, Julia AU - Lang, Irene TI - Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease DP - 2013 Sep 01 TA - European Respiratory Journal PG - P2627 VI - 42 IP - Suppl 57 4099 - http://erj.ersjournals.com/content/42/Suppl_57/P2627.short 4100 - http://erj.ersjournals.com/content/42/Suppl_57/P2627.full SO - Eur Respir J2013 Sep 01; 42 AB - PURPOSE: Pulmonary hypertension (PH) due to left heart disease (LHD) is the most common subset of PH. It is defined by an increase of mean pulmonary artery pressure (mPAP) ≥25mmHg in the presence of a mean pulmonary capillary wedge pressure (mPCWP) >15mmHg. In the current guidelines PH due to LHD with a TPG >12mmHg is labeled as “out-of-proportion” PH, as opposed to what is labeled as “passive” PH. Recent data have shown that patients with “out-of-proportion” PH and a diastolic pulmonary vascular pressure gradient (DPG) ≥7mmHg have an increased mortality and significant pulmonary vascular disease. We hypothesize that these patients may benefit from vasodilator treatment. The aim of this study was to compare the degree of acute vasoreactivity to inhaled nitric oxide (NO) in “out-of-proportion” PH with a DPG ≥7mmHg to that of “passive” PH and “out-of-proportion” PH with a DPG <7mmHg.METHODS: A prospective data set of 94 patients with PH due to LHD undergoing first diagnostic right heart catheterizations at rest and after inhalation of 40ppm NO was analyzed. 31 patients were classified as “passive” PH, 28 as “out-of-proportion” PH with a DPG <7mmHg and 35 as “out-of-proportion” PH with a DPG ≥7mmHg.RESULTS: The strongest decrease of mPAP was observed in patients with “out-of-proportion” PH and a DPG ≥7mmHg (-5.1±4.7mmHg, p<0.001). In contrast there was no significant change in mPAP in patients with “out-of-proportion” PH and a DPG <7mmHg (-2.2±5.9mmHg, p=0.075). In “passive” PH mPAP did not change upon NO inhalation.CONCLUSION: DPG identifies patients with “out-of-proportion” PH who have significant pulmonary vascular disease that is reactive to inhaled NO.